论文部分内容阅读
The phenotype and function of antigen-specific CD8 T cells are closely associated with the efficacy of a therapeutic vaccination.Here we showed that multiple immunizations with LCMV gp33-41 peptide(KAV)in Freund's adjuvant could induce KAV-specific CD8 T cells with low expression of CD127 and CD62L molecules.The inhibitory receptor PD-1 was also expressed on a substantial part of KAV-specific CD8 T cells,and its expression level on KAV-specific CD8 T cells in spleen and lymph nodes was much higher when compared to those in peripheral blood.Furthermore,KAV-specific CD8 T cells could specifically kill KAV-pulsed target cells in vivo but the efficiency was low.These data suggest that prime-boost vaccination schedule with peptide in Freund's adjuvant can elicit antigen-specific CD8 T cells of effector-like phenotype with partial functional exhaustion,which may only provide short-term protection against the pathogen.
The phenotype and function of antigen-specific CD8 T cells are closely associated with the efficacy of a therapeutic vaccination. Here we showed that multiple immunizations with LCMV gp33-41 peptide (KAV) in Freund's adjuvant could induce KAV-specific CD8 T cells with low expression of CD127 and CD62L molecules.The inhibitory receptor PD-1 was also expressed on a substantial part of KAV-specific CD8 T cells, and its expression level on KAV-specific CD8 T cells in spleen and lymph nodes was much higher when compared to those in peripheral blood. Stillrther, KAV-specific CD8 T cells could specifically kill KAV-pulsed target cells in vivo but the efficiency was low. the data suggest that prime-boost vaccination schedule with peptide in Freund's adjuvant can elicit antigen-specific CD8 T cells of effector-like phenotype with partial functional exhaustion, which may only provide short-term protection against the pathogen.